The legacy of Viagra and its originator, copyright, presents a complex picture for potential investors. While the iconic drug initially generated enormous revenues , its exclusivity has ended, leading to generic versions flooding the landscape . This decline in cost presents a real obstacle for copyright and any company considering a significant st